The right choice depends on goals, health history, side effects, and cost
Studies have shown the symptoms of intermittent claudication are notably reduced with L-carnitine supplementation
Similarly, once-a-day Saxenda (liraglutide) over 56 weeks led to an average of 8% weight loss, with 63% of participants experiencing clinically significant weight loss
Get Started Today Clinical References & Sources U.S
A After 12 weeks, those who received the supplement had improved prostate symptoms and increased levels of serum free testosterone
The MariTide Phase 2 data presented in November 2024 were highly significant: MariTide demonstrated robust weight loss at 52 weeks with no plateau meaning continued weight loss trajectory at the end of the study period, unlike semaglutide and tirzepatide which show plateau effects and significant improvements in cardiometabolic parameters